High Yield Intraoperative, Autologous Platelet Apheresis

计划入组 57 人 · 首次发布于 2013 年 3 月 27 日

Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis

计划入组 517 人 · 首次发布于 2009 年 3 月 27 日

Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis

计划入组 621 人 · 首次发布于 2006 年 10 月 19 日

European pilchard

AMC-303

AMC4

Invesco Rochester High Yield Municipal ETF

Amc Medical Research BV

Netherlands

Canopy Growth Corporation

Canada

Odiot Holding Secures €2.16M Capital Raise to Expand Luxury Silversmith Operations

Bristol-Myers Squibb Gains Momentum with Strong Earnings and Insider Confidence

AMC Health Receives FDA Clearance for AI-Powered Virtual Care Platform